Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion type Assertion NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_head.
- NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion description "[The other tumor that had a relatively high-frequency loss of ARID1A expression was gastric carcinoma (11%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_provenance.
- NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion evidence source_evidence_literature NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_provenance.
- NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion SIO_000772 21412130 NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_provenance.
- NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion wasDerivedFrom befree-20140225 NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_provenance.
- NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_assertion wasGeneratedBy ECO_0000203 NP352471.RA3Oil2sJs9IjiimOaTs9XHPkuCr7gluI3q3lFjTeKILY130_provenance.